Serono SA and Biogen Inc. continued to lob fire at each other in their battle to prove superiority in the multiple sclerosis drug space.(BioWorld Today)

Compound Therapeutics Inc. has hit the ground running after closing a $12 million Series A round of financing.(BioWorld Today)

Compound Therapeutics Inc. has hit the ground running after closing a $12 million Series A round of financing.(BioWorld Today)

EPIX Medical Inc. is returning to a familiar partner, Schering AG, to develop contrast agents for use in MRI in a deal that could garner up to $28 million in near-term money for EPIX.(BioWorld Today)